Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Revenues:
Total revenues	$ 19,262	$ 8,601	$ 49,426	$ 31,472
Costs and operating expenses:
Cost of product revenue	4,014	2,465	9,590	7,295
Research and development	12,587	13,868	35,741	40,586
Selling, general and administrative	10,097	11,217	30,803	35,889
Total costs and operating expenses	26,698	27,550	76,134	83,770
Loss from operations	(7,436)	(18,949)	(26,708)	(52,298)
Interest income	658	634	1,859	1,969
Interest and other expense, net	(1,341)	(1,292)	(3,933)	(3,217)
Loss before income taxes	(8,119)	(19,607)	(28,782)	(53,546)
Provision for income taxes	9	8	55	29
Net loss	$ (8,128)	$ (19,615)	$ (28,837)	$ (53,575)
Net loss per share, basic (in dollars per share)	$ (0.08)	$ (0.22)	$ (0.30)	$ (0.62)
Net loss per share, diluted (in dollars per share)	$ (0.08)	$ (0.22)	$ (0.30)	$ (0.62)
Weighted average common stock shares used in computing net loss per share, basic (in shares)	107,259	90,251	96,507	86,045
Weighted average common stock shares used in computing net loss per share, diluted (in shares)	107,259	90,251	96,507	86,045
Product revenue
Revenues:
Total revenues	$ 15,740	$ 6,807	$ 36,149	$ 20,246
Research and development revenue
Revenues:
Total revenues	$ 3,522	$ 1,794	$ 13,277	$ 11,226